When these experiments were reproduced after exposure to gemcitabine, we observed similar results in terms of increase of H2AX, CHK1, and p53 phosphorylation, accompanied by PARP cleavage in both CCA cell lines (Figure S2b and Figures S12–S13). The gene discussed is TP53; the disease is cholangiocarcinoma.